{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:13:58Z","timestamp":1759191238415,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-025-03211-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:04:06Z","timestamp":1759165446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tailoring treatment for esophageal cancer: a retrospective comparison of chemoradiation with and without esophagectomy"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0988-8988","authenticated-orcid":false,"given":"Piyapasara","family":"Toapichattrakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittinon","family":"Santasup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittisak","family":"Kittirungsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanapat","family":"Seemakajohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phubodee","family":"Kittiwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ausareeya","family":"Chumachote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6299-6606","authenticated-orcid":false,"given":"Bandhuphat","family":"Chakrabandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-2098","authenticated-orcid":false,"given":"Somvilai","family":"Chakrabandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"11","key":"3211_CR1","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/1759-7714.14835","volume":"14","author":"H Zhu","year":"2023","unstructured":"Zhu H, Wang Z, Deng B, Mo M, Wang H, Chen K, et al. Epidemiological landscape of esophageal cancer in Asia: results from GLOBOCAN 2020. Thorac Cancer. 2023;14(11):992\u20131003. https:\/\/doi.org\/10.1111\/1759-7714.14835.","journal-title":"Thorac Cancer"},{"issue":"10","key":"3211_CR2","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","volume":"33","author":"R Obermannova","year":"2022","unstructured":"Obermannova R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, et al. Oesophageal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):992\u20131004. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.003.","journal-title":"Ann Oncol"},{"key":"3211_CR3","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: esophageal and esophagogastric junction cancers.\u00a02024.\u00a0[cited 2024 Sep 1]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/esophageal.pdfN\u00a0"},{"issue":"3","key":"3211_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","volume":"20","author":"Y Kitagawa","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Ishikawa H, Ito Y, Oyama T, Oyama T, et al. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 1. Esophagus. 2023;20(3):343\u201372. https:\/\/doi.org\/10.1007\/s10388-023-00993-2.","journal-title":"Esophagus"},{"issue":"10","key":"3211_CR5","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","volume":"23","author":"M Stahl","year":"2005","unstructured":"Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23(10):2310\u20137. https:\/\/doi.org\/10.1200\/JCO.2005.00.034.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3211_CR6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","volume":"25","author":"L Bedenne","year":"2007","unstructured":"Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160\u20138. https:\/\/doi.org\/10.1200\/JCO.2005.04.7118.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3211_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1186\/s12885-024-12853-y","volume":"24","author":"J Yao","year":"2024","unstructured":"Yao J, Zhao X, Chen J, Liu T, Song Y, Dang J. Treatment strategies for elderly patients with locally advanced esophageal cancer: a systematic review and meta-analysis. BMC Cancer. 2024;24(1):1101. https:\/\/doi.org\/10.1186\/s12885-024-12853-y.","journal-title":"BMC Cancer"},{"issue":"1","key":"3211_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13014-021-01947-7","volume":"16","author":"J Park","year":"2021","unstructured":"Park J, Yea JW, Oh SA, Park JW. Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Radiat Oncol. 2021;16(1):219. https:\/\/doi.org\/10.1186\/s13014-021-01947-7.","journal-title":"Radiat Oncol"},{"issue":"2","key":"3211_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"issue":"6","key":"3211_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/jjco\/hyi095","volume":"35","author":"M Tahara","year":"2005","unstructured":"Tahara M, Ohtsu A, Hironaka S, Boku N, Ishikura S, Miyata Y, et al. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer. Jpn J Clin Oncol. 2005;35(6):316\u201323. https:\/\/doi.org\/10.1093\/jjco\/hyi095.","journal-title":"Jpn J Clin Oncol"},{"key":"3211_CR11","doi-asserted-by":"publisher","unstructured":"Mine S, Tanaka K, Kawachi H, Shirakawa Y, Kitagawa Y, Toh Y et al. Japanese Classification of Esophageal Cancer, 12th Edition: Part I. Esophagus. 2024;21(3):179\u2013215.\u00a0https:\/\/doi.org\/10.1007\/s10388-024-01054-y.","DOI":"10.1007\/s10388-024-01054-y"},{"key":"3211_CR12","doi-asserted-by":"publisher","unstructured":"Jiang G, Zhang L, Zhu Y, Chen C, Zhou X, Liu J, Zhang P, Wang H, Xie B, Wang H, Jiang L, Fan J, Zhao D, Chen Q, Duan L, He W, Zhou Y, Liu H, Zhao X, Qin X, Yang Y, Ning Y, Xie D, Dai J. Clinical consensus on preoperative pulmonary function assessment in patients undergoing pulmonary resection (first edition). Curr Chall Thorac Surg. 2019;1:7. https:\/\/doi.org\/10.21037\/ccts.2019.06.01.c","DOI":"10.21037\/ccts.2019.06.01.c"},{"key":"3211_CR13","doi-asserted-by":"publisher","unstructured":"Raslau D, Bierle DM, Stephenson CR, Mikhail MA, Kebede EB, Mauck KF. Preoperative Cardiac Risk Assessment. Mayo Clin Proc. 2020;95(5):1064-79.\u00a0https:\/\/doi.org\/10.1016\/j.mayocp.2019.08.013.","DOI":"10.1016\/j.mayocp.2019.08.013"},{"issue":"5","key":"3211_CR14","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.athoracsur.2019.05.053","volume":"108","author":"BC Chapman","year":"2019","unstructured":"Chapman BC, Weyant M, Hilton S, Hosokawa PW, McCarter MD, Gleisner A, et al. Analysis of the National Cancer Database esophageal squamous cell carcinoma in the United States. Ann Thorac Surg. 2019;108(5):1535\u201342. https:\/\/doi.org\/10.1016\/j.athoracsur.2019.05.053.","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"3211_CR15","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.21873\/anticanres.13707","volume":"39","author":"SR Park","year":"2019","unstructured":"Park SR, Yoon DH, Kim JH, Kim YH, Kim HR, Lee HJ, et al. A randomized phase III trial on the role of esophagectomy in complete responders to preoperative chemoradiotherapy for esophageal squamous cell carcinoma (ESOPRESSO). Anticancer Res. 2019;39(9):5123\u201333. https:\/\/doi.org\/10.21873\/anticanres.13707.","journal-title":"Anticancer Res"},{"issue":"8","key":"3211_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s11605-013-2269-3","volume":"17","author":"C Castoro","year":"2013","unstructured":"Castoro C, Scarpa M, Cagol M, Alfieri R, Ruol A, Cavallin F, et al. Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary? J Gastrointest Surg. 2013;17(8):1375\u201381. https:\/\/doi.org\/10.1007\/s11605-013-2269-3.","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"3211_CR17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.4143\/crt.2021.885","volume":"54","author":"J Yu","year":"2022","unstructured":"Yu J, Kim JH, Kim SB, Park SR, Kim YH, Kim HR, et al. Role of esophagectomy after chemoradiation therapy in patients with locally advanced squamous cell carcinoma: a comparative analysis stratified by clinical response to chemoradiation therapy. Cancer Res Treat. 2022;54(4):1148\u201356. https:\/\/doi.org\/10.4143\/crt.2021.885.","journal-title":"Cancer Res Treat"},{"issue":"5","key":"3211_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/SLA.0000000000000228","volume":"258","author":"G Piessen","year":"2013","unstructured":"Piessen G, Messager M, Mirabel X, Briez N, Robb WB, Adenis A, et al. Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. Ann Surg. 2013;258(5):793\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000000228. discussion 9-800.","journal-title":"Ann Surg"},{"issue":"1","key":"3211_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jtcvs.2008.05.016","volume":"137","author":"Y Tachimori","year":"2009","unstructured":"Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2009;137(1):49\u201354. https:\/\/doi.org\/10.1016\/j.jtcvs.2008.05.016.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9829","key":"3211_CR20","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/S0140-6736(12)60516-9","volume":"379","author":"SS Biere","year":"2012","unstructured":"Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379(9829):1887\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(12)60516-9.","journal-title":"Lancet"},{"issue":"7","key":"3211_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S1470-2045(18)30201-8","volume":"19","author":"BJ Noordman","year":"2018","unstructured":"Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, et al. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study. Lancet Oncol. 2018;19(7):965\u201374. https:\/\/doi.org\/10.1016\/S1470-2045(18)30201-8.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3211_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13063-021-05274-w","volume":"22","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, van der Wilk BJ, Noordman BJ, Wijnhoven BPL, Lagarde SM, Hartgrink HH, et al. Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer. Trials. 2021;22(1):345. https:\/\/doi.org\/10.1186\/s13063-021-05274-w.","journal-title":"Trials"},{"issue":"13","key":"3211_CR23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","volume":"384","author":"RJ Kelly","year":"2021","unstructured":"Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021;384(13):1191\u2013203. https:\/\/doi.org\/10.1056\/NEJMoa2032125.","journal-title":"N Engl J Med"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03211-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-03211-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03211-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:04:09Z","timestamp":1759165449000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-025-03211-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3211"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-03211-1","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Research Ethics Committee and Institutional Review Board (IRB), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand (Study Code: FAC-MED-2566-0546), and conducted in accordance with the Declaration of Helsinki. The committee was chaired by Emeritus Professor Panja Kulapongs. The requirement for informed consent was waived by the ethics committee due to the retrospective nature of the study and use of anonymized data. All patient data were de-identified and analyzed anonymously to protect confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"417"}}